AI-generated summary
The authors report a single-arm pilot of 40 adults with musculoskeletal pain who received a 10-session full-body red and near-infrared light protocol. Most respondents reported global improvement and would recommend the treatment, while the authors note the uncontrolled design, non-validated surveys and estimated post-treatment pain scores preclude efficacy conclusions.
- Participants
- 40
- Who or what was studied
- Adults with self-reported acute or chronic musculoskeletal pain, predominantly Hispanic/Latino community sample (87.5% Hispanic/Latino, 62.5% female, mean age 37.2 years)
- Wavelengths
- 630, 660, 830, 850 nm
- Limits stated in the abstract
- The uncontrolled single-arm design, non-validated survey outcomes and estimated rather than directly measured post-intervention pain scores preclude efficacy conclusions.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Pilot study, Light-emitting diode, Dosimetry, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.